Notal Visions homebased OCT system gets FDA breakthrough device status

Notal Vision’s home-based OCT system gets FDA breakthrough device status

06:20 EST 4 Dec 2018 | Compelo Medical Devices

The breakthrough device designation is said to indicate that the FDA intends to offer interactive and timely communication with the sponsor during device development and across the review

The post Notal Vision’s home-based OCT system gets FDA breakthrough device status appeared first on Compelo Medical Devices.

More From BioPortfolio on "Notal Vision’s home-based OCT system gets FDA breakthrough device status"